ArticleTargeted oncology2024

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.

Margherita Rimini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.